Robert Coury

Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Beckers Hospital Review
Thu, 04/16/20 - 11:07 am
Mylan
Robert Coury
Upjohn
generics
M&A
COVID-19
pandemic
The EpiPen maker’s chairman earned more than $97 million last year — and investors aren’t happy
Washington Post, DC
Sun, 06/25/17 - 06:21 pm
Mylan Labs
EpiPens
executive pay
Robert Coury
Mylan's Coury caps a year of controversy with $97M exit-pay package
Fierce Pharma
Tue, 05/2/17 - 11:20 am
Mylan Labs
executive pay
Robert Coury
Mylan says CEO Coury to step down; shares rise
Reuters
Wed, 10/26/11 - 11:04 am
Mylan
Pharma CEOs
Robert Coury